NovaBone Products Receives 510(k) Clearance for Wound Dressing for the Advanced Wound Market

NovaBone Products, a UF startup and a leader in synthetic biologics, has received clearance from the U.S. Food and Drug Administration (FDA) for its proprietary Wound Matrix product – first of its kind collagen + 45S5 bioactive glass device for the wound care market.

NovaBone’s Wound Matrix is a fully resorbable, sterile, single-use device intended for the management of partial and full-thickness wounds; pressure, venous, diabetic, and chronic vascular ulcers; and tunneled, surgical, trauma, and draining wounds.

“We are thrilled to obtain FDA clearance for Wound Matrix. This is our first product in the advanced wound care market. Our core technology platforms of bioactive glass and collagen combined with our manufacturing capability, uniquely position us to provide this differentiated product in the wound care space,” said Sameer Paranjpe, VP of R&D and Operations at NovaBone.

Read more about NovaBone Products Receives 510(k) Clearance for Wound Dressing for the Advanced Wound Market.